ICOGEN, NCT01040780: Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients |
|
|
| Completed | 3 | 399 | RoW | Icotinib, BPI-2009, Conmana, Gefitinib, ZD1839, Iressa | Betta Pharmaceuticals Co., Ltd. | Non-small Cell Lung Cancer | 03/10 | 12/11 | | |
NCT01724801: Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer |
|
|
| Completed | 3 | 176 | RoW | whole brain radiation(WBI), Icotinib | Guangdong Association of Clinical Trials, Guangdong Provincial People's Hospital | Brain Metastasis, Non Small Cell Lung Cancer | 06/15 | 09/16 | | |
ICTAN, NCT01996098: Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation |
|
|
| Recruiting | 3 | 318 | RoW | 6-month Icotinib, BPI-2009, Conmana, 12-month icotinib | Sun Yat-sen University | Lung Cancer | 01/20 | 01/23 | | |
